CLOZAPINE FOR THE TREATMENT-RESISTANT SCHIZOPHRENIC - RESULTS OF A UNITED-STATES MULTICENTER TRIAL

被引：38

作者：

KANE, JM

HONIGFELD, G

SINGER, J

MELTZER, H

机构：

[1] SANDOZ RES INST,E HANOVER,NJ 07936

[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PSYCHIAT,BRONX,NY 10461

[3] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,PISCATAWAY,NJ 08854

[4] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PSYCHIAT,CLEVELAND,OH 44106

来源：

关键词：

D O I：

10.1007/BF00442561

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：S60 / S63

页数：4

共 9 条

[1] CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377
[2] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
CREESE, I
BURT, DR
SNYDER, SH
[J]. SCIENCE, 1976, 192 (4238) : 481 - 483
[3] IMPORTANT ISSUES IN THE DRUG-TREATMENT OF SCHIZOPHRENIA
DAVIS, JM
SCHAFFER, CB
KILLIAN, GA
KINARD, C
CHAN, C
[J]. SCHIZOPHRENIA BULLETIN, 1980, 6 (01) : 70 - 87
[4] FISCHER-CORNELSSEN K A, 1976, Psychopharmacology Bulletin, V12, P34
[5] GRIFFITH RW, 1975, LANCET, V2, P657
[6] CLOZAPINE - PLASMA-LEVELS AND PROLACTIN RESPONSE
KANE, JM
COOPER, TB
SACHAR, EJ
HALPERN, FS
BAILINE, S
[J]. PSYCHOPHARMACOLOGY, 1981, 73 (02) : 184 - 187
[7] Klein D. F., 1969, DIAGNOSIS DRUG TREAT
[8] MELTZER HY, 1979, AM J PSYCHIAT, V136, P1550
[9] CONTROVERSY IN COUNTING AND ATTRIBUTING EVENTS IN CLINICAL-TRIALS
SACKETT, DL
GENT, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (26) : 1410 - 1412